The IGF1R pathway is aberrantly activated by autocrine and paracrine signaling loops in neuroblastoma tumors through the release of IGF1 and IGF2, ligands for IGF1R, from the neuroblastoma and stromal cells within the tumor [22,23,24,25]. The gene discussed is IGF1R; the disease is neoplasm.